Thiazolidinediones in the treatment of Type 2 diabetes

By Greenberg Andrew S   Pittas Anastassios G  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. : 529-540

Informa Healthcare

Access to resources Recommend Favorite

Thiazolidinediones in Type 2 Diabetes Mellitus: Current Clinical Evidence

By Diamant M.   Heine R.J.  

Drugs, Vol. 63, Iss. 13, 2003-01 ,pp. : 1373-1405

Adis International

Access to resources Recommend Favorite

Thiazolidinediones Anti-Inflammatory and Anti-Atherosclerotic Effects in Type 2 Diabetes Mellitus

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 217-223

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1498-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study of over 473 000 Patients Using the National Health Insurance Database in Taiwan

By Hsiao Fei-Yuan   Huang Weng-Foung  

Drug Safety, Vol. 32, Iss. 8, 2009-08 ,pp. : 675-690

Adis International

Access to resources Recommend Favorite